PubMed:32213337 / 2008-2239 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T49","span":{"begin":21,"end":26},"obj":"UBERON:0001977"},{"id":"T50","span":{"begin":129,"end":132},"obj":"GO:0071735"},{"id":"T51","span":{"begin":157,"end":160},"obj":"GO:0071735"},{"id":"T52","span":{"begin":187,"end":190},"obj":"GO:0071735"},{"id":"T53","span":{"begin":220,"end":223},"obj":"GO:0071735"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"For 16 patients with serum samples available 14 days or longer after symptom onset, rates of seropositivity were 94% for anti-NP IgG (n=15), 88% for anti-NP IgM (n=14), 100% for anti-RBD IgG (n=16), and 94% for anti-RBD IgM (n=15)."}

{"project":"LitCovid-OGER","denotations":[{"id":"T22","span":{"begin":21,"end":26},"obj":"GO:0005790"},{"id":"T12","span":{"begin":21,"end":26},"obj":"UBERON:0001977"}],"namespaces":[{"prefix":"PR","uri":"http://purl.obolibrary.org/obo/PR_"},{"prefix":"UBERON","uri":"http://purl.obolibrary.org/obo/UBERON_"}],"text":"For 16 patients with serum samples available 14 days or longer after symptom onset, rates of seropositivity were 94% for anti-NP IgG (n=15), 88% for anti-NP IgM (n=14), 100% for anti-RBD IgG (n=16), and 94% for anti-RBD IgM (n=15)."}

{"project":"LitCovid-sentences-v1","denotations":[{"id":"TextSentencer_T20","span":{"begin":0,"end":231},"obj":"Sentence"}],"text":"For 16 patients with serum samples available 14 days or longer after symptom onset, rates of seropositivity were 94% for anti-NP IgG (n=15), 88% for anti-NP IgM (n=14), 100% for anti-RBD IgG (n=16), and 94% for anti-RBD IgM (n=15)."}

{"project":"LitCovid-TimeML","denotations":[{"id":"tok391","span":{"begin":0,"end":3},"obj":"IN"},{"id":"tok392","span":{"begin":4,"end":6},"obj":"CD"},{"id":"tok393","span":{"begin":7,"end":15},"obj":"NNS"},{"id":"tok394","span":{"begin":16,"end":20},"obj":"IN"},{"id":"tok395","span":{"begin":21,"end":26},"obj":"NN"},{"id":"tok396","span":{"begin":27,"end":34},"obj":"NNS"},{"id":"tok397","span":{"begin":35,"end":44},"obj":"JJ"},{"id":"tok398","span":{"begin":45,"end":47},"obj":"CD"},{"id":"tok399","span":{"begin":48,"end":52},"obj":"NNS"},{"id":"tok400","span":{"begin":53,"end":55},"obj":"CC"},{"id":"tok401","span":{"begin":56,"end":62},"obj":"RBR"},{"id":"tok402","span":{"begin":63,"end":68},"obj":"IN"},{"id":"tok403","span":{"begin":69,"end":76},"obj":"NN"},{"id":"tok404","span":{"begin":77,"end":82},"obj":"NN"},{"id":"tok405","span":{"begin":82,"end":83},"obj":","},{"id":"tok406","span":{"begin":84,"end":89},"obj":"NNS"},{"id":"tok407","span":{"begin":90,"end":92},"obj":"IN"},{"id":"tok408","span":{"begin":93,"end":107},"obj":"NN"},{"id":"tok409","span":{"begin":108,"end":112},"obj":"VBD"},{"id":"tok410","span":{"begin":113,"end":115},"obj":"CD"},{"id":"tok411","span":{"begin":115,"end":116},"obj":"NN"},{"id":"tok412","span":{"begin":117,"end":120},"obj":"IN"},{"id":"tok413","span":{"begin":121,"end":126},"obj":"NN"},{"id":"tok414","span":{"begin":126,"end":128},"obj":"NNP"},{"id":"tok415","span":{"begin":129,"end":132},"obj":"NNP"},{"id":"tok416","span":{"begin":133,"end":134},"obj":"("},{"id":"tok417","span":{"begin":134,"end":135},"obj":"NN"},{"id":"tok418","span":{"begin":135,"end":136},"obj":"SYM"},{"id":"tok419","span":{"begin":136,"end":138},"obj":"CD"},{"id":"tok420","span":{"begin":138,"end":139},"obj":")"},{"id":"tok421","span":{"begin":139,"end":140},"obj":","},{"id":"tok422","span":{"begin":141,"end":143},"obj":"CD"},{"id":"tok423","span":{"begin":143,"end":144},"obj":"NN"},{"id":"tok424","span":{"begin":145,"end":148},"obj":"IN"},{"id":"tok425","span":{"begin":149,"end":154},"obj":"NN"},{"id":"tok426","span":{"begin":154,"end":156},"obj":"NNP"},{"id":"tok427","span":{"begin":157,"end":160},"obj":"NNP"},{"id":"tok428","span":{"begin":161,"end":162},"obj":"("},{"id":"tok429","span":{"begin":162,"end":163},"obj":"NN"},{"id":"tok430","span":{"begin":163,"end":164},"obj":"SYM"},{"id":"tok431","span":{"begin":164,"end":166},"obj":"CD"},{"id":"tok432","span":{"begin":166,"end":167},"obj":")"},{"id":"tok433","span":{"begin":167,"end":168},"obj":","},{"id":"tok434","span":{"begin":169,"end":172},"obj":"CD"},{"id":"tok435","span":{"begin":172,"end":173},"obj":"NN"},{"id":"tok436","span":{"begin":174,"end":177},"obj":"IN"},{"id":"tok437","span":{"begin":178,"end":183},"obj":"NN"},{"id":"tok438","span":{"begin":183,"end":186},"obj":"NNP"},{"id":"tok439","span":{"begin":187,"end":190},"obj":"NNP"},{"id":"tok440","span":{"begin":191,"end":192},"obj":"("},{"id":"tok441","span":{"begin":192,"end":193},"obj":"NN"},{"id":"tok442","span":{"begin":193,"end":194},"obj":"SYM"},{"id":"tok443","span":{"begin":194,"end":196},"obj":"CD"},{"id":"tok444","span":{"begin":196,"end":197},"obj":")"},{"id":"tok445","span":{"begin":197,"end":198},"obj":","},{"id":"tok446","span":{"begin":199,"end":202},"obj":"CC"},{"id":"tok447","span":{"begin":203,"end":205},"obj":"CD"},{"id":"tok448","span":{"begin":205,"end":206},"obj":"NN"},{"id":"tok449","span":{"begin":207,"end":210},"obj":"IN"},{"id":"tok450","span":{"begin":211,"end":216},"obj":"NN"},{"id":"tok451","span":{"begin":216,"end":219},"obj":"NNP"},{"id":"tok452","span":{"begin":220,"end":223},"obj":"NNP"},{"id":"tok453","span":{"begin":224,"end":225},"obj":"("},{"id":"tok454","span":{"begin":225,"end":226},"obj":"NN"},{"id":"tok455","span":{"begin":226,"end":227},"obj":"SYM"},{"id":"tok456","span":{"begin":227,"end":229},"obj":"CD"},{"id":"tok457","span":{"begin":229,"end":230},"obj":")"},{"id":"tok458","span":{"begin":230,"end":231},"obj":"."},{"id":"lookup38","span":{"begin":0,"end":3},"obj":"stop"},{"id":"lookup39","span":{"begin":48,"end":52},"obj":"date_unit"},{"id":"lookup40","span":{"begin":115,"end":116},"obj":"percent"},{"id":"lookup41","span":{"begin":143,"end":144},"obj":"percent"},{"id":"lookup42","span":{"begin":172,"end":173},"obj":"percent"},{"id":"lookup43","span":{"begin":205,"end":206},"obj":"percent"}],"text":"For 16 patients with serum samples available 14 days or longer after symptom onset, rates of seropositivity were 94% for anti-NP IgG (n=15), 88% for anti-NP IgM (n=14), 100% for anti-RBD IgG (n=16), and 94% for anti-RBD IgM (n=15)."}

{"project":"LitCovid-PD-FMA-UBERON-v1","denotations":[{"id":"T19","span":{"begin":21,"end":26},"obj":"Body_part"},{"id":"T20","span":{"begin":129,"end":132},"obj":"Body_part"},{"id":"T21","span":{"begin":157,"end":160},"obj":"Body_part"},{"id":"T22","span":{"begin":187,"end":190},"obj":"Body_part"},{"id":"T23","span":{"begin":220,"end":223},"obj":"Body_part"}],"attributes":[{"id":"A19","pred":"fma_id","subj":"T19","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A90036","pred":"uberon_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"},{"id":"A20","pred":"fma_id","subj":"T20","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A21","pred":"fma_id","subj":"T21","obj":"http://purl.org/sig/ont/fma/fma62873"},{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma62873"}],"text":"For 16 patients with serum samples available 14 days or longer after symptom onset, rates of seropositivity were 94% for anti-NP IgG (n=15), 88% for anti-NP IgM (n=14), 100% for anti-RBD IgG (n=16), and 94% for anti-RBD IgM (n=15)."}